• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶Cη/还原酶驱动的3-磷酸肌醇依赖性蛋白激酶-1磷酸化:促进癌细胞存活及细小病毒诱导裂解易感性的新机制

PKCη/Rdx-driven phosphorylation of PDK1: a novel mechanism promoting cancer cell survival and permissiveness for parvovirus-induced lysis.

作者信息

Bär Séverine, Rommelaere Jean, Nüesch Jürg P F

机构信息

Infection and Cancer Program, Tumor Virology Division (F010), German Cancer Research Center (DKFZ), Heidelberg, Germany.

出版信息

PLoS Pathog. 2015 Mar 5;11(3):e1004703. doi: 10.1371/journal.ppat.1004703. eCollection 2015 Mar.

DOI:10.1371/journal.ppat.1004703
PMID:25742010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4351090/
Abstract

The intrinsic oncotropism and oncosuppressive activities of rodent protoparvoviruses (PVs) are opening new prospects for cancer virotherapy. Virus propagation, cytolytic activity, and spread are tightly connected to activation of the PDK1 signaling cascade, which delays stress-induced cell death and sustains functioning of the parvoviral protein NS1 through PKC(η)-driven modifications. Here we reveal a new PV-induced intracellular loop-back mechanism whereby PKCη/Rdx phosphorylates mouse PDK1:S138 and activates it independently of PI3-kinase signaling. The corresponding human PDK1phosphoS135 appears as a hallmark of highly aggressive brain tumors and may contribute to the very effective targeting of human gliomas by H-1PV. Strikingly, although H-1PV does not trigger PDK1 activation in normal human cells, such cells show enhanced viral DNA amplification and NS1-induced death upon expression of a constitutively active PDK1 mimicking PDK1phosphoS135. This modification thus appears as a marker of human glioma malignant progression and sensitivity to H-1PV-induced tumor cell killing.

摘要

啮齿动物细小病毒(PVs)的内在亲肿瘤性和抑癌活性为癌症病毒疗法开辟了新前景。病毒增殖、细胞溶解活性和传播与PDK1信号级联的激活紧密相关,该信号级联延迟应激诱导的细胞死亡,并通过PKC(η)驱动的修饰维持细小病毒蛋白NS1的功能。在这里,我们揭示了一种新的PV诱导的细胞内反馈机制,即PKCη/Rdx磷酸化小鼠PDK1:S138并独立于PI3激酶信号激活它。相应的人类PDK1磷酸化S135表现为高度侵袭性脑肿瘤的一个标志,可能有助于H-1PV对人类胶质瘤的高效靶向作用。引人注目的是,尽管H-1PV在正常人类细胞中不会触发PDK1激活,但当表达模拟PDK1磷酸化S135的组成型活性PDK1时,这些细胞会显示出增强的病毒DNA扩增和NS1诱导的死亡。因此,这种修饰似乎是人类胶质瘤恶性进展和对H-1PV诱导的肿瘤细胞杀伤敏感性的一个标志。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7db/4351090/3c958c7f1213/ppat.1004703.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7db/4351090/7e915217ceb5/ppat.1004703.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7db/4351090/292bbab4903c/ppat.1004703.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7db/4351090/e72397b2892c/ppat.1004703.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7db/4351090/9442f2af7c88/ppat.1004703.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7db/4351090/1e39248e59bc/ppat.1004703.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7db/4351090/c6aa564d1ef3/ppat.1004703.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7db/4351090/9bd7df328cde/ppat.1004703.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7db/4351090/3c958c7f1213/ppat.1004703.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7db/4351090/7e915217ceb5/ppat.1004703.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7db/4351090/292bbab4903c/ppat.1004703.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7db/4351090/e72397b2892c/ppat.1004703.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7db/4351090/9442f2af7c88/ppat.1004703.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7db/4351090/1e39248e59bc/ppat.1004703.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7db/4351090/c6aa564d1ef3/ppat.1004703.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7db/4351090/9bd7df328cde/ppat.1004703.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7db/4351090/3c958c7f1213/ppat.1004703.g008.jpg

相似文献

1
PKCη/Rdx-driven phosphorylation of PDK1: a novel mechanism promoting cancer cell survival and permissiveness for parvovirus-induced lysis.蛋白激酶Cη/还原酶驱动的3-磷酸肌醇依赖性蛋白激酶-1磷酸化:促进癌细胞存活及细小病毒诱导裂解易感性的新机制
PLoS Pathog. 2015 Mar 5;11(3):e1004703. doi: 10.1371/journal.ppat.1004703. eCollection 2015 Mar.
2
Regression of glioma in rat models by intranasal application of parvovirus h-1.经鼻腔内应用细小病毒 H-1 使大鼠模型中的神经胶质瘤消退。
Clin Cancer Res. 2011 Aug 15;17(16):5333-42. doi: 10.1158/1078-0432.CCR-10-3124. Epub 2011 Jun 29.
3
Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models.溶瘤细小病毒 H-1 局部或全身治疗大鼠和人高级神经胶质瘤的实验研究。
Neuro Oncol. 2010 Aug;12(8):804-14. doi: 10.1093/neuonc/noq023. Epub 2010 Mar 18.
4
Parvovirus interference with intracellular signalling: mechanism of PKCeta activation in MVM-infected A9 fibroblasts.细小病毒对细胞内信号传导的干扰:MVM感染的A9成纤维细胞中PKCeta激活的机制
Cell Microbiol. 2008 Mar;10(3):755-69. doi: 10.1111/j.1462-5822.2007.01082.x. Epub 2007 Nov 27.
5
A Roadmap for the Success of Oncolytic Parvovirus-Based Anticancer Therapies.溶瘤细小病毒为基础的抗癌疗法成功路线图。
Annu Rev Virol. 2020 Sep 29;7(1):537-557. doi: 10.1146/annurev-virology-012220-023606. Epub 2020 Jun 29.
6
Therapeutic implications of the enhanced short and long-term cytotoxicity of radiation treatment followed by oncolytic parvovirus H-1 infection in high-grade glioma cells.在高级别胶质瘤细胞中,放疗后再进行溶瘤性细小病毒H-1感染所增强的短期和长期细胞毒性的治疗意义。
Bioeng Bugs. 2010 Nov-Dec;1(6):429-33. doi: 10.4161/bbug.1.6.12943.
7
Improved killing of human high-grade glioma cells by combining ionizing radiation with oncolytic parvovirus H-1 infection.通过将电离辐射与溶瘤细小病毒H-1感染相结合提高对人类高级别胶质瘤细胞的杀伤作用。
J Biomed Biotechnol. 2010;2010:350748. doi: 10.1155/2010/350748. Epub 2010 Mar 7.
8
Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1.化学治疗或靶向药物联合溶瘤细小病毒 H-1 激活人体免疫系统。
BMC Cancer. 2011 Oct 26;11:464. doi: 10.1186/1471-2407-11-464.
9
Parvovirus H1 selectively induces cytotoxic effects on human neuroblastoma cells.细小病毒 H1 选择性诱导人神经母细胞瘤细胞的细胞毒性作用。
Int J Cancer. 2010 Sep 1;127(5):1230-9. doi: 10.1002/ijc.25168.
10
SMAD4: a predictive marker of PDAC cell permissiveness for oncolytic infection with parvovirus H-1PV.SMAD4:预测胰腺导管腺癌细胞对细小病毒 H-1PV 溶瘤感染的易感性的标志物。
Int J Cancer. 2010 Jun 15;126(12):2914-27. doi: 10.1002/ijc.24992.

引用本文的文献

1
Generation and Validation of Monoclonal Antibodies Suitable for Detecting and Monitoring Parvovirus Infections.适用于检测和监测细小病毒感染的单克隆抗体的产生与验证
Pathogens. 2022 Feb 4;11(2):208. doi: 10.3390/pathogens11020208.
2
Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry.溶瘤 H-1 微小病毒通过与层粘连蛋白上的唾液酸结合来实现细胞附着和进入。
Nat Commun. 2021 Jun 22;12(1):3834. doi: 10.1038/s41467-021-24034-7.
3
H-1 Parvovirus as a Cancer-Killing Agent: Past, Present, and Future.H-1 微小病毒作为一种癌症杀伤剂:过去、现在和未来。

本文引用的文献

1
Tumor suppressing properties of rodent parvovirus NS1 proteins and their derivatives.啮齿动物细小病毒NS1蛋白及其衍生物的肿瘤抑制特性。
Adv Exp Med Biol. 2014;818:99-124. doi: 10.1007/978-1-4471-6458-6_5.
2
Vesicular transport of progeny parvovirus particles through ER and Golgi regulates maturation and cytolysis.子代微小病毒颗粒通过内质网和高尔基体的囊泡运输调节成熟和细胞裂解。
PLoS Pathog. 2013 Sep;9(9):e1003605. doi: 10.1371/journal.ppat.1003605. Epub 2013 Sep 19.
3
Molecular pathways: rodent parvoviruses--mechanisms of oncolysis and prospects for clinical cancer treatment.
Viruses. 2019 Jun 18;11(6):562. doi: 10.3390/v11060562.
4
Atomic Resolution Structure of the Oncolytic Parvovirus LuIII by Electron Microscopy and 3D Image Reconstruction.电子显微镜和 3D 图像重建解析溶瘤细小病毒 LuIII 的原子分辨率结构。
Viruses. 2017 Oct 30;9(11):321. doi: 10.3390/v9110321.
5
The tumor promoter-activated protein kinase Cs are a system for regulating filopodia.肿瘤启动子激活的蛋白激酶C是一个调控丝状伪足的系统。
Cytoskeleton (Hoboken). 2017 Aug;74(8):297-314. doi: 10.1002/cm.21373. Epub 2017 May 24.
6
Role of the phosphatidylinositol-3-kinase/Akt/target of rapamycin pathway during ambidensovirus infection of insect cells.磷脂酰肌醇-3-激酶/蛋白激酶B/雷帕霉素靶蛋白信号通路在昆虫细胞感染双顺反子病毒过程中的作用
J Gen Virol. 2016 Jan;97(1):233-245. doi: 10.1099/jgv.0.000327. Epub 2015 Oct 26.
7
Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients.溶瘤细小病毒的肿瘤选择性:从体外和动物模型到癌症患者。
Front Bioeng Biotechnol. 2015 Apr 22;3:55. doi: 10.3389/fbioe.2015.00055. eCollection 2015.
分子途径:细小病毒--溶瘤机制和临床癌症治疗的前景。
Clin Cancer Res. 2012 Jul 1;18(13):3516-23. doi: 10.1158/1078-0432.CCR-11-2325. Epub 2012 May 7.
4
Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol.一项在进展性原发性或复发性多形性胶质母细胞瘤患者中瘤内/颅内或静脉内/颅内给予细小病毒 H-1(ParvOryx)的 I/IIa 期研究:ParvOryx01 方案。
BMC Cancer. 2012 Mar 21;12:99. doi: 10.1186/1471-2407-12-99.
5
PKCη is a negative regulator of AKT inhibiting the IGF-I induced proliferation.PKCη 是 AKT 的负调控因子,抑制 IGF-I 诱导的增殖。
Exp Cell Res. 2012 Apr 15;318(7):789-99. doi: 10.1016/j.yexcr.2012.01.018. Epub 2012 Jan 28.
6
Targeting PDK1 in cancer.针对癌症的 PDK1 靶点。
Curr Med Chem. 2011;18(18):2763-9. doi: 10.2174/092986711796011238.
7
Multiple implications of 3-phosphoinositide-dependent protein kinase 1 in human cancer.3-磷酸肌醇依赖性蛋白激酶1在人类癌症中的多重影响
World J Biol Chem. 2010 Aug 26;1(8):239-47. doi: 10.4331/wjbc.v1.i8.239.
8
The FERM family proteins in cancer invasion and metastasis.FERM 家族蛋白在癌症侵袭和转移中的作用。
Front Biosci (Landmark Ed). 2011 Jan 1;16(4):1536-50. doi: 10.2741/3803.
9
To kill or be killed: how viruses interact with the cell death machinery.生死抉择:病毒如何与细胞死亡机制相互作用。
J Intern Med. 2010 May;267(5):473-82. doi: 10.1111/j.1365-2796.2010.02222.x.
10
3-phosphoinositide-dependent protein kinase-1 regulates proliferation and survival of cancer cells with an activated mitogen-activated protein kinase pathway.3-磷酸肌醇依赖的蛋白激酶-1 通过调节有丝分裂原激活的蛋白激酶通路调节增殖和存活的癌细胞。
Mol Cancer Res. 2010 Mar;8(3):421-32. doi: 10.1158/1541-7786.MCR-09-0179. Epub 2010 Mar 2.